FDA Reports First Drug Shortage Over Coronavirus Outbreak: ‘We Will Do Everything Possible’

The headquarters of the Food and Drug Administration (FDA) is seen in Silver Spring, Md., on Nov. 4, 2009. Jason Reed/Reuters

The U.S. Food and Drug Administration (FDA) said it’s been alerted to the first manufacturing shortage of a drug due to the COVID-19 coronavirus outbreak that originated in China.

FDA Commissioner Stephen Hahn told reporters that his agency is “closely monitoring” the medical supply chain, saying that the COVID-19 outbreak—which has started to affect other countries in Asia and Europe—will “likely” have an impact.